| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
Colorado Center for Reproductive Medicine, 799 E Hampden Ave, Suite 520, Englewood, Colorado 80113, USA
Correspondence should be addressed to M Katz-Jaffe; Email: mkatz-jaffe{at}colocrm.com
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
To date, research has concentrated on identifying and localising individual proteins; however physiological processes predominantly involve more than a single biochemical pathway or molecular interaction. The classic proteomics approach involves 2D polyacrylamide gel electrophoresis, requires large amounts of starting material, is complex, labour-intensive and not capable of high throughput analysis (Latham et al. 1992, Shi et al. 1994). In addition, proteins with low or high molecular masses or that are very acidic, basic or hydrophobic can be under-represented in 2D gels. Recent developments in mass spectrometry have been revolutionary, utilising expression profiling and peptide sequencing to identify the proteins that are expressed and that function in a biological system (Hale et al. 2003, Shanker et al. 2005). Comparative protein profiling has been developed for the detection of specific protein expression patterns reflecting varying biological states (Shau et al. 2003, Rocken et al. 2004). One method, surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS), involves affinity-based mass spectrometry whereby proteins are absorbed to a chemically modified surface (e.g. cationic or anionic) or to a biochemical molecular surface (e.g. receptors or ligands). These different chip surfaces allow the different classes of proteins (hydrophobic, hydrophilic, acidic or basic) to be captured for analysis. Laser activation irradiates the sample and desorption/ionisation liberates gaseous ions to a constant final energy. Time-of-flight mass spectrometry then accurately determines the mass-to-charge ratio (m/z) of the bound protein by the time it takes for the ions to pass through the long flight tube from the laser pulse to the detector (Merchant & Weinberger 2000). SELDI-TOF MS has been shown to capture, detect and analyse proteins directly from crude biological fluids, such as serum (Seibert et al. 2004, Buhimschi et al. 2005, Xiao et al. 2005). It is a highly sensitive, high throughput and cost-effective method that has been used to identify biomarkers/changes in protein expression from varying disease states including early detection for ovarian cancer (Zhang et al. 2004), cervical cancer (Wong et al. 2004) and kidney cancer (Junker et al. 2005). Biomarkers are defined as candidate proteins or peptides that are either down- or up-regulated in response to different physiological states.
In order to elucidate embryonic cellular function, a detailed understanding at the protein level is necessary. The major technical issues when it comes to studying the mammalian embryonic proteome include the constraint of requiring large amounts of sample and the difficulty in obtaining sufficient biological material to identify low-abundance proteins by mass spectrometry. To date, studies have focused on investigating individual proteins using large numbers of embryos. Wang et al.(2005) reported the analysis from groups of over 100 mice embryos of the expression of stress-activated protein kinase/Jun kinase (SAPK/JNK) phosphoproteins and p38 mitogen-activated protein kinases (MAPKs) by Western blotting. Another study identified the expression of a major vault protein (MVP) in porcine zygotes cultured in the presence of a specific proteosomal inhibitor using matrix-assisted laser-desorption ionisation-time-of-flight (MALDI-TOF) peptide sequencing and Western blotting (Sutovsky et al. 2005). MVP was also observed to accumulate in poor quality human oocytes and porcine embryos that failed to develop in vitro. In addition, two insulin-responsive glucose transporter isoforms (GLUT4 and GLUT8) and the insulin receptor proteins were confirmed by Western blotting as being present in rabbit blastocysts (Navarette Santos et al. 2004). However, the only work published describing a proteomics approach in mammalian in vitro fertilisation (IVF) is a study analysing porcine oocyte protein patterns and their variations during in vitro maturation. Up to 600 porcine oocytes were used to separate and visualise proteins of interest by 2D gel electrophoresis. Identification of potential oocyte proteins involved peptide profiling by MALDI-TOF and peptide sequencing by liquid chromatography-tandem mass spectrometry (Ellederova et al. 2004).
In this study, the objective was first to develop a proteomics approach for the generation of protein profiles from small numbers of mammalian embryos, followed by an analysis of protein patterns throughout all stages of preimplantation development to identify proteins that are stage specific. Furthermore, the effects of oxygen concentration (a known regulator of embryonic development) during in vitro development on embryonic cellular function at the protein level were analysed. A comparative analysis to identify potential proteins/bio-markers that are differentially expressed was subsequently undertaken.
| Materials and Methods |
|---|
|
|
|---|
Cation and anion exchange chromatography
Groups of 5 embryos were extracted in 5 µl lysis buffer (9 M urea/2% CHAPS; Sigma), pulse vortexed and stored at 80 °C until further processing. Cationic (CM10) and anionic (Q10) protein chips were washed several times with binding buffers, 0.1 M sodium acetate, pH 4.0, and 50 mM Tris-HCl, pH 9, respectively. The samples were allowed to react with the surface of the protein chip for 30 min at room temperature. The unbound sample was discarded and each spot was washed three times with the same binding buffer for 5-min intervals to remove non-specific binding. The chips were then quickly rinsed with distilled water before air-drying. Sinapinic acid, an energy absorbing molecule (Ciphergen Biosystems, Freemont, CA, USA) was prepared as a saturated solution in 50% acetonitrile/0.5% trifluoroacetic acid and each spot was loaded with 2 x 1 µl of the prepared solution. The protein chips were air dried again and immediately subjected to mass spectrometry.
SELDI-TOF MS
Mass spectrometry (MS) was performed using the PCS-4000 Series SELDI-TOF MS (Ciphergen Biosystems). Mass accuracy was calibrated to <0.1% with the all-in-one peptide molecular mass standard for the mass range of <20 kDa (Ciphergen Biosystems). Time-of-flight data were collected from averaged 530 laser shots per spot capturing peptides and proteins <20 000 Da. Spectra were generated by Ciphergen Express Software (Ciphergen Biosystems).
Bioinformatic analysis
Protein profiles were analysed for differences in expression with Proteinchip Software Biomarker Edition, version 3.1 (Ciphergen Biosystems). Peaks with a signal-to-noise ratio higher than 6 were first selected, profiles were then normalised to the total ion current and hierarchical clustering was performed to group samples with similar proteins of mass-to-charge ratios (m/z). Significant differences (P < 0.05) in peak height between proteins from different groups were calculated using a Mann-Whitney non-parametric test. To test between-chip and between-run variation, one sample was analysed in triplicate and the coefficient of variance of individual peaks in the replicate spectra was calculated by dividing the standard deviation by the mean peak height multiplied by 100%.
| Results |
|---|
|
|
|---|
Figure 1
shows the gel and line plot data of CM10 data enhanced around the 60007000 Da range for in vitro-produced (5% oxygen) embryos. There appear to be clusters of proteins only produced after day 2 of development, as well as other proteins that appear only in the spectra of day 2 embryos. For the Q10 data, a similar situation is observed in Fig. 2
showing gel and line plots of data enhanced around the 800012 000 Da range.
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The development of a proteomics approach using SELDI-TOF MS in this report has led to the discovery of biomarkers associated with in vivo mammalian embryonic development. These biomarkers represent optimal cellular function and provide a potential diagnostic platform for improving IVF procedure including the further improvement of in vitro culture conditions, stimulation protocols and cryopreservation techniques. In addition, panels of proteins/biomarkers that are specific to each of the individual developmental stages were successfully identified. Due to the multifactorial nature of embryonic development, it is possible that a combination of several biomarkers will be necessary to effectively diagnose developmental competence.
The data also revealed that a specific pattern of 10 bio-markers (P < 0.05) effectively discriminated in vitro embryos cultured at low oxygen concentrations (5%) from in vitro embryos cultured at high oxygen concentrations (20%), and that embryos cultured in the presence of a reduced oxygen concentration exhibited a more in vivo-like profile. Oxygen at a concentration of 20% (atmospheric) has been shown to adversely affect embryonic development compared with embryos cultured at 5% (Quinn & Harlow 1978, Batt et al. 1991, Gardner & Lane 1996). These data further support the notion that it is not appropriate to culture the preimplantation mammalian embryo in the presence of atmospheric oxygen.
In order to utilise this proteomic approach accurately it is important that experimental procedures and quality control for the SELDI-TOF MS are well calibrated and standardised and that all biomarkers are validated in large studies.
As well as the obvious clinical applications of improving the management of infertile patients and facilitating the clinical application of potentially new diagnostic technologies, this proteomics approach gives researchers an opportunity to expand our knowledge at the cellular level of mammalian preimplantation development including the maternalembryonic dialogue at the time of implantation. Future experiments will also involve the purification and identification of a selected number of these candidate bio-markers. Identification of these biomarkers will provide mechanistic insight into the biological processes occurring at the cellular level during preimplantation embryonic development. It is also plausible that the identification of these proteins could assist with the detection of viability. From a clinical perspective, quantification of viability potential will result in an increase in IVF pregnancy rates and live births, while reducing the number of embryos transferred.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Batt PA, Gardner DK & Cameron AWN 1991 Oxygen concentration and protein source affect the development of preimplantation goat embryos in vitro. Reproduction Fertility and Development 3 601607.[CrossRef][Medline]
Buhimschi IA, Christner R & Buhimschi CS 2005 Proteomic bio-marker analysis of amniotic fluid for identification of intra-amniotic inflammation. British Journal of Obstetrics and Gynaecology 112 173181 .
Ellederova Z, Halada P, Man P, Kubelka M, Motlik J & Kovarova H 2004 Protein patterns of pig oocytes during in vitro maturation. Biology of Reproduction 71 15331539.
Gardner DK & Lane M 1996 Alleviation of the 2-cell block and development to the blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical parameters. Human Reproduction 11 27032712.
Gardner DK & Lane M 2003 Towards a single embryo transfer. Reproductive Biomedicine Online 6 470481.[Medline]
Hale JE, Gelfanova V, Ludwig JR & Kniermen MD 2003 Application of proteomics for discovery of protein biomarkers. Briefings in Functional Genomics and Proteomics 2 185193.
Junker K, Gneist J, Melle C, Driesch D, Schubert J, Claussen U & Von Eggeling F 2005 Identification of protein pattern in kidney cancer using ProteinChip arrays and bioinformatics. International Journal of Molecular Medicine 15 285290.[Web of Science][Medline]
Latham KE, Garrels JI, Chang C & Solter D 1992 Analysis of embryonic mouse development: construction of a high-resolution, two-dimensional gel protein database. Applied and Theoretical Electrophoresis 2 163170.
Merchant M & Weinberger SR 2000 Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21 11641177.[CrossRef][Web of Science][Medline]
Navarette Santos A, Tonack S, Kirstein M, Kietz S & Fischer B 2004 Two insulin-responsive glucose transporter isoforms and the insulin receptor are developmentally expressed in rabbit preimplantation embryos. Reproduction 128 503516.
Quinn P & Harlow GH 1978 The effect of oxygen on the development of preimplantation mouse embryos in vitro. Journal of Experimental Zoology 206 7380.
Rocken C, Ebert M & Roessner A 2004 Proteomics in pathology, research and practice. PathologyResearch and Practice 200 6982.
Shankar R, Gude N, Cullinane F, Brennecke S, Purcell AW & Moses EK 2005 An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction 129 685696.
Shau H, Chandler S, Whitelegge JP, Gornbein JA, Faull KF & Chang HR 2003 Proteomic profiling of cancer biomarkers. Briefings in Functional Genomics and Proteomics 2 147158 .
Shi CZ, Collins HW, Garside WT, Buettger CW, Matschinsky FM & Heyner S 1994 Protein databases for compacted eight-cell and blastocyststage mouse embryos. Molecular Reproduction and Development 37 3447.[CrossRef][Web of Science][Medline]
Siebert V, Wiesner A, Buschmann T & Meuer J 2004 Surface-enhanced laser desorption ionization time-of-flight (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathology Research and Practice 200 8394 .
Sutovsky P, Manandhar G, Laurincik J, Letko J, Caamano JN, Day BN & Lai L 2005 Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and embryos. Reproduction 129 269282 .
Wang Y, Puscheck EE, Lewis JJ, Trostinskaia AB, Wang F & Rappolee DA 2005 Increases in phosphorylation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture in different media. Fertility and Sterility 83 11441154.
Wong YF, Cheung TH, Lo KWK, Wang VW, Chan CS, Ng TB, Chung TKH & Mok SC 2004 Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix. Cancer Letters 211 227234.[CrossRef][Web of Science][Medline]
Xiao Z, Prieto D, Conrads TP, Veenstra TD & Issaq HJ 2005 Proteomic patterns: their potential for disease diagnosis. Molecular and Cellular Endocrinology 230 95106.[CrossRef][Web of Science][Medline]
Zhang Z, Bast RC, Yu Y, Li J, Sokoll LJ, Rai AJ & Rosenzweig JM et al. 2004 Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Research 64 58825890.
This article has been cited by other articles:
![]() |
M.G. Katz-Jaffe, S. McReynolds, D.K. Gardner, and W.B. Schoolcraft The role of proteomics in defining the human embryonic secretome Mol. Hum. Reprod., May 1, 2009; 15(5): 271 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dominguez, A. Pellicer, and C. Simon The Human Embryo Proteome Reproductive Sciences, February 1, 2009; 16(2): 188 - 190. [Abstract] [PDF] |
||||
![]() |
F. Dominguez, B. Gadea, F. J. Esteban, J. A. Horcajadas, A. Pellicer, and C. Simon Comparative protein-profile analysis of implanted versus non-implanted human blastocysts Hum. Reprod., September 1, 2008; 23(9): 1993 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.G. Larman, M.G. Katz-Jaffe, C.B. Sheehan, and D.K. Gardner 1,2-propanediol and the type of cryopreservation procedure adversely affect mouse oocyte physiology Hum. Reprod., January 1, 2007; 22(1): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |